ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 461

Involvement of CD163-Positive Macrophages in the Pathogenesis of Arthritis Via Modulation of Inflammatory Cytokine and Chemokine Expression in the Synovium of a Murine Model

Shinjiro Kaieda1, Hiroaki Ida2 and Tomoaki Hoshino3, 1Department of Medicine, *Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, kurume, Japan, 2Respiorogy, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan, 3Department of Medicine, Division of Respirology, Neurology and Rheumatology, Kurume University School of Medicine, Kurume, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: arthritis and neutrophils, Macrophage

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Animal Models - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:   Synovial-lining macrophages play a crucial role in the onset and maintenance of joint inflammation in arthritis. CD68 and CD163 are commonly used markers of synovial macrophages in the RA synovium. CD163 is a cell-surface glycoprotein of the group B cysteine-rich scavenger receptor family that binds to and internalizes hemoglobin-haptoglobin complexes, thereby releasing IL-10 and carbon oxide with strong anti-inflammatory effects. Serum-soluble CD163 levels are significantly elevated in long-standing RA patients. The restrictive expression of CD163 by monocytes-macrophages was confirmed in the affected joint tissues of RA patients; however, the pathogenic roles of CD163-positive macrophages in inflammatory arthritis remain unclear. We investigated the roles of CD163-positive macrophages in arthritis development in mice.

Methods:   A collagen antibody-induced arthritis (CAIA) mouse model was established with a combination of monoclonal anti-type II collagen antibodies and lipopolysaccharide in C57BL/6 (B6)-background CD163 knockout (KO) mice. Arthritis was graded using a 0–16 clinical scale (0–4) per paw. Histological assessment of arthritis severity was performed on paraffin-embedded hematoxylin and eosin-stained sections, and synovial inflammation (inflammatory cell infiltration) and bone erosion were graded in a blinded fashion on an established 0–5 scale. Anti-Iba-1 and anti-NIMP-R14 antibodies were used for immunocytochemical staining to identify synovial tissue-resident macrophages and neutrophils, respectively. Anti-CD163 antibodies were used for histomorphometric quantitation of CD163-positive macrophages in the synovial tissue. Total RNA was isolated from the mouse ankle joints for gene expression analysis of pro-inflammatory cytokines IL-1β and IL-6 and the chemokine CXCL-1 before and 10 days after CAIA induction by quantitative RT-PCR.

Results:   Immunohistochemistry revealed that CD163 antigens were restricted to Iba-1-positive synovial tissue-resident macrophages. The number of CD163-positive cells increased during arthritis. CD163 KO mice exhibited significant exacerbation of clinical scores during arthritis compared with control wild type (WT) B6 mice. Histomorphometric quantification of the arthritic changes in the joint tissues confirmed the clinical assessment, with significant increases in inflammation and bone erosion scores in CD163 KO mice. Recruitment of neutrophils was significantly increased in the synovial tissue of CD163 KO mice compared to that of WT mice. Correspondingly, mRNA expression of CXCL1 was significantly more up-regulated in the inflamed ankle joints obtained from CD163 KO mice than control mice. Additionally, CD163 KO mice showed significantly elevated IL-1b and IL-6 mRNA expression levels in the inflamed synovium.

Conclusion:   CD163 deficiency exacerbates arthritis severity via up-regulation of synovial tissue IL-1b and IL-6. CD163-positive macrophage deficiency induced neutrophil recruitment via up-regulation of CXCL1 in the inflamed synovium. CD163-positive macrophages may play an inhibitory role in the pathogenesis of joint inflammation.


Disclosure: S. Kaieda, None; H. Ida, None; T. Hoshino, None.

To cite this abstract in AMA style:

Kaieda S, Ida H, Hoshino T. Involvement of CD163-Positive Macrophages in the Pathogenesis of Arthritis Via Modulation of Inflammatory Cytokine and Chemokine Expression in the Synovium of a Murine Model [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/involvement-of-cd163-positive-macrophages-in-the-pathogenesis-of-arthritis-via-modulation-of-inflammatory-cytokine-and-chemokine-expression-in-the-synovium-of-a-murine-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/involvement-of-cd163-positive-macrophages-in-the-pathogenesis-of-arthritis-via-modulation-of-inflammatory-cytokine-and-chemokine-expression-in-the-synovium-of-a-murine-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology